About us

Johnson & Johnson is committed to transforming the world's vision. We strive to increase awareness of the importance of vision and vision care and to provide the world's best vision correction choices.

Building on a 135-year legacy of helping people

Johnson & Johnson is committed to transforming the world's vision. We strive to increase awareness of the importance of vision and vision care and to provide the world's best vision correction choices. Called to put people first, we are backed by pioneering spirit and the power of Johnson & Johnson, one of the world’s largest healthcare companies, with 150,000+ global employees, adding a mix of clinical capabilities, regulatory know-how, and technical expertise.

We care for over 40 million people’s vision each year1

Sight is a key component in the way many of us experience the world, learn and remember, and what many fear losing the most. Vision is the most dominant of the five senses and plays a crucial role in every facet of our lives.2

Our vision: To be the leader in eye health for a patient’s lifetime journey.

Our mission: To help every human see their world clearly. 

Our Credo

The values that guide our decision making are spelled out in Our Credo. Put simply, Our Credo challenges us to put the needs and well-being of the people we serve first.

Robert Wood Johnson, former chairman from 1932 to 1963 and a member of the Company's founding family, crafted Our Credo himself in 1943, just before Johnson & Johnson became a publicly traded company. This was long before anyone ever heard the term "corporate social responsibility." Our Credo is more than just a moral compass. We believe it's a recipe for business success. The fact that Johnson & Johnson is one of only a handful of companies that have flourished through more than a century of change is proof of that.

Additional information illustrating Our Credo Values can be found here.

1. JJV Data on File, 2022. Growth Levers analysis based on lpsos Global Incidence Tracker, retail outlet consumption data and national census population data covering United States, United Kingdom, Russia, Japan, South Korea and China in 2022.

2. World report on vision. Geneva: World Health Organization; 2019. Page 3. License: CC BY-NC-SA 3.0 IGO.

2025PP07667
Johnson & Johnson
Important Safety Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For detailed product information, including contraindications, precautions and adverse reactions, please consult the lnstructions for Use available on Johnson & Johnson website https://www.e-ifu.com/. Important Safety Information: ACUVUE Revitalens Multi-Purpose Disinfecting Solution (MPDS) is indicated for the care of soft (hydrophilic) contact lenses, including silicone hydrogel lenses. For detailed product information, including warnings and precautions, please consult the Instructions for Use. Failure to do so may result in serious eye infection or injury.  © Janssen-Cilag AS. 2025. All rights reserved. This site is published by Janssen-Cilag AS, which is solely responsible for its content. It is intended for use by Eye Care Professionals in Norway. ACUVUE®, 1-DAY ACUVUE® MOIST, 1-DAY ACUVUE® MOIST for ASTIGMATISM, 1-DAY ACUVUE® MOIST MULTIFOCAL, ACUVUE® OASYS, ACUVUE® OASYS MULTIFOCAL, ACUVUE® OASYS for ASTIGMATISM, ACUVUE® OASYS 1-Day for ASTIGMATISM, ACUVUE® OASYS 1-Day, ACUVUE® OASYS MAX 1-Day, ACUVUE® OASYS MAX 1-Day MULTIFOCAL, ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM, ACUVUE® OASYS MAX 1-Day for ASTIGMATISM, ACUVUE RevitaLens, TearStable, OptiBlue, LACREON®, EYE-INSPIRED and HydraLuxe® are trademarks of Johnson & Johnson. Third-party trademarks used herein are trademarks of their respective owners. Last Update: Last Update: July 2, 2025.